Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Charles & Colvard ( (CTHR) ) has provided an update.
Charles & Colvard, Ltd. announced that its common stock will be delisted from the Nasdaq Stock Market due to non-compliance with the timely filing of financial reports. The company has decided not to appeal this decision, and trading will be suspended on April 25, 2025. Following the delisting, the company’s stock is expected to be quoted on the OTC Experts Market, although there is no assurance of an active trading market.
Spark’s Take on CTHR Stock
According to Spark, TipRanks’ AI Analyst, CTHR is a Underperform.
The overall score for Charles & Colvard is low due to several factors. Financial performance is notably poor, with substantial revenue decline and persistent losses, although the balance sheet remains relatively strong. Technical indicators suggest a bearish outlook, and valuation metrics highlight the company’s unprofitability. Furthermore, a recent legal settlement introduces additional financial strain. These combined elements suggest significant challenges ahead, with a need for strategic redirection to improve financial health and investor confidence.
To see Spark’s full report on CTHR stock, click here.
More about Charles & Colvard
Charles & Colvard, Ltd. is a company based in North Carolina’s Research Triangle Park region, known for creating lab-grown moissanite and fine jewelry. They focus on ethical jewelry production using Made, not Mined™ gemstones and 100% recycled precious metals. Their brands include Forever One™ moissanite and Caydia® lab-grown diamonds, catering to bridal, high fashion, and everyday jewelry markets.
YTD Price Performance: -40.28%
Average Trading Volume: 30,993
Technical Sentiment Signal: Strong Buy
Current Market Cap: $2.68M
See more insights into CTHR stock on TipRanks’ Stock Analysis page.